Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation.
about
Atrial fibrillation in a primary care practice: prevalence and managementPatients' perspectives on taking warfarin: qualitative study in family practiceA randomized trial to assess the impact of an antithrombotic decision aid in patients with nonvalvular atrial fibrillation: the DAAFI trial protocol [ISRCTN14429643]Randomized trial evaluating the framing of cardiovascular risk and its impact on blood pressure control [ISRCTN87597585]Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesDeveloping an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making.Clinical and Economic Implications of AF Related StrokeDifferences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational studyPreference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision makingA patient decision aid to support shared decision-making on anti-thrombotic treatment of patients with atrial fibrillation: randomised controlled trialMedical communication and technology: a video-based process study of the use of decision aids in primary care consultations.A cautionary note on data sources for evidence-based clinical decisions: warfarin and stroke preventionThe cost of monitoring warfarin in patients with chronic atrial fibrillation in primary care in SwedenEffects of patients' preferences on the treatment of atrial fibrillation: observational study of patient-based decision analysis.Cost-effectiveness of apixaban compared with warfarin for stroke prevention in atrial fibrillationProfessional centred shared decision making: patient decision aids in practice in primary care.Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study.Impact of a patient decision aid on care among patients with nonvalvular atrial fibrillation: a cluster randomized trial.A factorial randomised controlled trial of decision analysis and an information video plus leaflet for newly diagnosed hypertensive patientsCost-effectiveness of dabigatran versus genotype-guided management of warfarin therapy for stroke prevention in patients with atrial fibrillationMeasuring patients' preferences for treatment and perceptions of riskAn Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment.Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy.Development and description of a decision analysis based decision support tool for stroke prevention in atrial fibrillation.Cost-effectiveness of clopidogrel-aspirin versus aspirin alone for acute transient ischemic attack and minor strokePatient values and preferences when choosing anticoagulantsMeta-analysis and decision analysis bridge research and practice.Cost-effectiveness of anticoagulation in patients with nonvalvular atrial fibrillation with edoxaban compared to warfarin in Germany.Cost-effectiveness analysis of left atrial appendage occlusion compared with pharmacological strategies for stroke prevention in atrial fibrillationBenefits and harms associated with hormone replacement therapy: clinical decision analysisA pilot randomized controlled trial of a decision support tool to improve the quality of communication and decision-making in individuals with atrial fibrillationCost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL.Potential impact of new oral anticoagulants on the management of atrial fibrillation-related stroke in primary care.European Society of Cardiology Guideline-Adherent Antithrombotic Treatment and Risk of Mortality in Asian Patients with Atrial FibrillationThe role of patients' meta-preferences in the design and evaluation of decision support systems.Women's views of two interventions designed to assist in the prophylactic oophorectomy decision: a qualitative pilot evaluationThe impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis.Novel oral anticoagulants versus warfarin therapy at various levels of anticoagulation control in atrial fibrillation--a cost-effectiveness analysis.Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis.Incorporating the patient perspective: a critical review of clinical practice guidelines for implantable cardioverter defibrillator therapy.
P2860
Q24795377-C76EEF1B-D3C5-4C7C-8410-9A2C7D6E1986Q24798132-87938E4E-8842-4A36-8516-A6FB26DA1146Q24803243-2F59AC15-4C5E-4B8A-928A-D5828B985E1BQ24806491-D3DC7A14-624F-45E6-91D4-2B2A294C33DCQ27027290-6ACE4C9E-2DE0-4B24-A419-648A7B2B1270Q27321275-61B1453C-C2BB-469B-9175-E2BF7BA12EA2Q28077788-9F02E467-1AF5-40E1-A7F2-14AF3C7D6390Q28191755-5DF12D25-E7D2-4B46-8AA1-DA144E68BEBAQ28191848-D0B77AC8-D88C-4580-8E67-0B2413A9899BQ28212218-859949E0-B4FF-4EC3-9ED7-5517E5A6F61BQ28217506-ADDA9ACA-26D7-40D9-9141-3C9E58F7799DQ28218659-F37B7137-4A50-4034-A72A-9078BF1FE118Q28219446-27C63314-951C-4591-A503-F133A3961CD8Q28364493-64593318-480E-4783-AB58-1726D8AB4C5FQ28484289-D383E6B4-881F-4AFC-A5DB-A01245BD450BQ30481320-BD82D912-85F7-416A-A8A3-F052AB600CEEQ30491866-F5C907C0-6F5D-49B7-84F7-75625F738782Q33920598-4E9A8352-9048-43EC-A6D5-0DEF2EF22F63Q34223762-8BCA88E7-EC72-4150-8A0D-D4A90BAE51C7Q34321590-5AAF7F5D-4A8E-4AAD-82D9-D18CAFB321E1Q34354172-AAC6260D-0A9B-42E9-93E2-D430BB4273D8Q34548875-1EA1EFEE-2173-4BF7-B20D-5FDC0505B1F5Q34667522-B99C942F-70CE-40D7-B5EE-2C0A5D33A2CFQ34700318-3C6485EE-0864-4212-8C8A-F79E92F1C875Q35021898-7B036636-B8A9-4C8A-A495-A86128F7B5C4Q35024233-FB548562-AF40-4070-B75C-4E302D47051AQ35094994-A2ADA5EF-09C1-47BA-9500-F85180CF5242Q35234175-C7B1B958-3A78-410E-910A-DF7B19E558DAQ36119172-2C8473B3-8EDE-48E2-97F5-CB8435F030ECQ36147214-6BC8CC33-8661-4466-B08F-97CC986A6962Q36164759-6C6A6168-78C7-4013-B31E-FD5194080226Q37015495-7D60CC05-9496-4900-90A1-A2F99FB6F779Q37108889-DA27FCDF-930F-4C9A-AB8B-015CE072E93DQ37157549-ED281C1D-7D23-4789-BA51-7EA3AA86B74CQ37331428-71910357-0B36-4C93-B505-F5B98EFF9FADQ37331469-626B7C94-5B30-4DA4-851F-7449CEFB7BA0Q37333837-6ADD828C-3431-49AF-9D49-57D6258BFC3CQ37595758-B5B91A9F-1F47-4D48-BB94-FEB6F9D7FA96Q37868373-4F54760E-B1AC-4E3A-BACF-63EFE5348FD5Q38068334-A13C3E6D-F6A8-4946-A28F-A2520D01D9ED
P2860
Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Decision analysis and guidelin ...... ents with atrial fibrillation.
@ast
Decision analysis and guidelin ...... ents with atrial fibrillation.
@en
type
label
Decision analysis and guidelin ...... ents with atrial fibrillation.
@ast
Decision analysis and guidelin ...... ents with atrial fibrillation.
@en
prefLabel
Decision analysis and guidelin ...... ents with atrial fibrillation.
@ast
Decision analysis and guidelin ...... ents with atrial fibrillation.
@en
P2093
P1433
P1476
Decision analysis and guidelin ...... ents with atrial fibrillation.
@en
P2093
P304
P356
10.1016/S0140-6736(00)90012-6
P407
P577
2000-03-01T00:00:00Z